Avalon GloboCare (AVCO) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
markets.businessinsider.com logoAvalon’s Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device
markets.businessinsider.com - September 13 at 11:13 AM
markets.businessinsider.com logoAvalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT)
markets.businessinsider.com - September 5 at 4:15 PM
finance.yahoo.com logoAvalon’s Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis
finance.yahoo.com - August 30 at 12:37 PM
finance.yahoo.com logoAvalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
finance.yahoo.com - July 24 at 10:32 AM
investing.com logoAvalon Globocare Corp (ALBT)
investing.com - April 22 at 8:04 PM
finance.yahoo.com logoAvalon GloboCare to Participate in the 35th Annual Roth Conference
finance.yahoo.com - March 3 at 3:28 PM
detroitnews.com logoAvalon reopens in Midtown on Canfield Wednesday with 25 cent cookies
detroitnews.com - March 1 at 8:12 PM
finance.yahoo.com logoAvalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”
finance.yahoo.com - November 9 at 7:40 PM
proactiveinvestors.com logoAvalon Globocare enters 'transformative' deal to acquire majority stake in Laboratory Services MSO
proactiveinvestors.com - November 8 at 6:35 PM
proactiveinvestors.com logoBiotech junior climbs on acquisition deal: Proactive’s daily small cap movers
proactiveinvestors.com - November 8 at 1:34 PM
seekingalpha.com logoAvalon GloboCare to acquire a 60% interest in Laboratory Services MSO, LLC
seekingalpha.com - November 8 at 1:34 PM
proactiveinvestors.com logoAvalon GloboCare to acquire majority interest in Laboratory Services MSO in 'transformative' deal worth $31M
proactiveinvestors.com - November 8 at 1:34 PM
finance.yahoo.com logoEXCLUSIVE: Avalon GloboCare Acquires Majority Stake In Premier Reference Laboratory
finance.yahoo.com - November 8 at 1:34 PM
finance.yahoo.com logoAvalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million
finance.yahoo.com - November 8 at 1:34 PM
marketbeat.com logo
marketbeat.com - November 8 at 8:55 AM
finance.yahoo.com logoInvestors in Avalon GloboCare (NASDAQ:AVCO) from five years ago are still down 72%, even after 32% gain this past week
finance.yahoo.com - November 8 at 8:34 AM
finance.yahoo.com logoAvalon Globocare to Present at the LD Micro Main Event XV on October 26th
finance.yahoo.com - October 19 at 9:28 AM
proactiveinvestors.com logoAvalon GloboCare gets notice of allowance from US patent office for QTY fusion platform
proactiveinvestors.com - September 29 at 1:50 PM
finance.yahoo.com logoAvalon GloboCare Receives Allowance for Joint U.S. Patent
finance.yahoo.com - September 29 at 1:50 PM
seekingalpha.com logoAVCO Avalon GloboCare Corp.
seekingalpha.com - September 16 at 8:41 AM
uk.finance.yahoo.com logoAvalon GloboCare Corp. (AVCO)
uk.finance.yahoo.com - September 10 at 10:50 AM
nasdaq.com logoInvestors in Avalon GloboCare (NASDAQ:AVCO) have unfortunately lost 82% over the last five years
nasdaq.com - September 9 at 9:28 AM
proactiveinvestors.com logoAvalon GloboCare says its co-developed QTY code protein code technology featured in Chemical Reviews
proactiveinvestors.com - August 8 at 2:52 PM
finance.yahoo.com logoAvalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society
finance.yahoo.com - August 8 at 2:52 PM
ca.proactiveinvestors.com logoAvalon GloboCare reveals new study using AI-powered protein design technology targeting glucose transporter against cancer
ca.proactiveinvestors.com - June 30 at 11:52 AM
finance.yahoo.com logoAvalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer
finance.yahoo.com - June 30 at 11:52 AM
finance.yahoo.com logoEven after rising 13% this past week, Avalon GloboCare (NASDAQ:AVCO) shareholders are still down 73% over the past three years
finance.yahoo.com - June 1 at 7:31 AM
finance.yahoo.com logoAvalon GloboCare to Present at the Jefferies 2022 Healthcare Conference
finance.yahoo.com - May 25 at 12:04 PM
proactiveinvestors.com logoAvalon GloboCare to team up with Lu Daopei Hematology Institute to develop companion diagnostics for CAR-T cancer treatments
proactiveinvestors.com - May 18 at 5:06 PM
finance.yahoo.com logoAvalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy
finance.yahoo.com - May 18 at 9:20 AM
proactiveinvestors.com.au logoAvalon GloboCare files 16 patent applications related to cellular therapies as company moves towards clinical trials
proactiveinvestors.com.au - April 27 at 3:38 PM
seekingalpha.com logoAvalon GloboCare stock gains after expanding IP portfolio with 16 new patent applications
seekingalpha.com - April 27 at 10:38 AM
finance.yahoo.com logoAvalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications
finance.yahoo.com - April 27 at 10:37 AM
benzinga.com logoAvalon Globocare Says Received Notice On Feb. 9 Co Received Notice From Nasdaq That Co Not In Compliance With Minimum Bid Price Requirement
benzinga.com - February 16 at 1:35 PM
finance.yahoo.com logoAvalon GloboCare Adds CAR-NK Cell Therapies To Expand Cellular Immuno-Oncology Platform
finance.yahoo.com - February 14 at 4:28 PM
proactiveinvestors.com logoAvalon GloboCare expands its cellular immuno-oncology program with addition of Chimeric Antigen Receptor-Natural Killer cell therapies
proactiveinvestors.com - February 14 at 11:26 AM
finance.yahoo.com logoAvalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies
finance.yahoo.com - February 14 at 11:26 AM
finance.yahoo.com logoAvalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
finance.yahoo.com - January 4 at 1:21 PM
finance.yahoo.com logoAvalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market
finance.yahoo.com - December 22 at 12:48 PM
finance.yahoo.com logoAvalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market
finance.yahoo.com - December 22 at 12:48 PM
benzinga.com logoNASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO)
benzinga.com - December 10 at 2:23 PM
proactiveinvestors.com logoAvalon GloboCare advances its AI-enhanced protein design technology for cellular therapy development in collaboration with MIT
proactiveinvestors.com - December 9 at 1:00 PM
finance.yahoo.com logoAvalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development
finance.yahoo.com - December 9 at 1:00 PM
nasdaq.com logoHere's Why Avalon GloboCare (NASDAQ:AVCO) Can Afford Some Debt
nasdaq.com - December 6 at 12:30 PM
finance.yahoo.com logoShareholders in Avalon GloboCare (NASDAQ:AVCO) are in the red if they invested three years ago
finance.yahoo.com - December 6 at 7:29 AM
prnewswire.com logoAVALON GLOBOCARE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Avalon GloboCare Corp. - AVCO
prnewswire.com - November 11 at 11:58 PM
finance.yahoo.com logoAvalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy
finance.yahoo.com - October 14 at 1:31 PM
proactiveinvestors.com logoAvalon GloboCare announces co-development of in-silico system to...
proactiveinvestors.com - October 8 at 9:38 AM
finance.yahoo.com logoAvalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases
finance.yahoo.com - October 7 at 1:52 PM
finance.yahoo.com logoAvalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
finance.yahoo.com - October 7 at 1:52 PM
Get Avalon GloboCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVCO and its competitors with MarketBeat's FREE daily newsletter.

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

AVCO Media Mentions By Week

AVCO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVCO
News Sentiment

0.00

0.42

Average
Business Services
News Sentiment

AVCO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVCO Articles
This Week

0

0

AVCO Articles
Average Week

Get Avalon GloboCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVCO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AVCO) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners